REYKJAVIK, Iceland, March 27 /PRNewswire-FirstCall/ -- deCODE genetics today announced that CEO Kari Stefansson will present at BioCentury’s 13th annual Future Leaders in the Biotech Industry conference on Thursday, March 30. The presentation will be delivered at 4:00 pm EST/9:00 pm GMT at the Millennium Broadway hotel in New York and will be webcast live.
The webcast can be accessed through the Investors page on deCODE’s website, http://www.decode.com. Those interested in listening should log on a few minutes in advance in order to download any software or complete any sign-in that may be required.
About deCODE
deCODE genetics is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery -- our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the basic biology of disease. deCODE is also leveraging its expertise in human genetics and integrated drug discovery and development capabilities to offer innovative products and services in DNA-based diagnostics, bioinformatics, genotyping, structural biology, drug discovery and clinical development. deCODE is delivering on the promise of the new genetics(SM). Visit us on the web at http://www.decode.com.
Contact: deCODE genetics Stefan Arnason +354 570 1995 ir@decode.is
deCODE genetics
CONTACT: Stefan Arnason of deCODE genetics, +354-570-1995, ir@decode.is
Web site: http://www.decode.com/
